39 Nexium Bone Density Suits Consolidated By MDL Panel
The U.S. Judicial Panel on Multidistrict Litigation on Thursday consolidated 39 suits claiming the AstraZeneca LP heartburn drug Nexium causes bone density loss, shooting down the pharmaceutical company's argument that distinct...To view the full article, register now.
Already a subscriber? Click here to view full article